HCA holds 6.5% upside to analyst target before earnings
Alpha Vantage · AD HOC NEWS · · AI-summarised by FinFlash
Cantor Fitzgerald reiterated an Overweight rating and a USD 525.00 price target on HCA Healthcare ahead of its Q3 earnings call on October 27, 2026. The target sits 22.9 percent above the stock's October 2 closing price of USD 427.09. HCA reported Q2 2026 revenue of USD 20.23 billion and beat EPS consensus, despite payer pressure and the expiration of certain payment program funds.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.